NSE, an enzyme that released after neuronal damage, has been investigated as a biomarker for brain injury, including conditions such as central nervous system infections, hypoxic-ischemic encephalopathy and traumatic brain injury [25, 26]. This evidence concerns the gene ENO2 and central nervous system infectious disorder.